文献速递牙体牙髓病

阿奇霉素在实验性根尖周炎症中的免疫调节作用

Immunomodulation Mediated by Azithromycin in Experimental Periapical Inflammation.
PubMed 文献 · J Endod · 2020-08-05

本研究比较阿奇霉素(AZM)与氨苄西林(AMP)、阿莫西林(AMX)、克林霉素(CLI)对4种根管病原菌的体外敏感性,并在C57BL/6J小鼠已存在的根尖周病变中比较AZM与AMP治疗10天后的骨愈合和炎症细胞浸润模式。结果显示AZM显著减轻根尖周骨丧失,促进中性粒细胞和M2巨噬细胞局部浸润及纤维化,并抑制病原菌刺激的NF-κB活化和细胞因子产生,而AMP对骨的作用不确定且以M1巨噬细胞为主。

要点

  • AZM对4种根管病原菌均敏感,且显著减轻小鼠根尖周骨丧失。
  • AZM促进中性粒细胞和M2巨噬细胞局部浸润及纤维化,AMP以M1巨噬细胞为主。
  • AZM抑制病原菌刺激的NF-κB活化和IL-1α、TNF-α产生,其他抗生素仅中度降低细胞因子。

核心结论

  • AZM可促进实验性根尖周炎症的消退,其作用可能依赖免疫调节效应。
  • AZM与AMP均对已存在的根尖周病变有效,但AZM带来更先进的伤口愈合。
  • 需要设计良好的临床试验来阐明AZM作为根管治疗辅助疗法的益处。

研究设计与样本

  • 体外实验:用琼脂纸片扩散法确认4种根管病原菌对AZM、AMP、AMX和CLI的敏感性。
  • 动物实验:C57BL/6J小鼠已存在的根尖周病变分别用AZM、AMP或PBS治疗10天。
  • 体外机制实验:用荧光素酶法和ELISA评估抗生素对病原菌刺激的NF-κB活化及IL-1α、TNF-α产生的影响。

主要发现

  • 所有受试根管病原菌均对AZM、AMP、AMX和CLI敏感。
  • AZM较PBS显著减轻根尖周骨丧失。
  • PBS组可见混合炎症细胞广泛弥漫浸润;AZM组为中性粒细胞和M2巨噬细胞局部浸润并伴晚期纤维化。
  • AMP对骨的作用不确定,但炎症细胞浸润较PBS明显减轻,多数巨噬细胞似为M1型。
  • AZM抑制病原菌刺激的NF-κB活化和细胞因子产生,而AMP、AMX和CLI仅中度降低细胞因子产生。

关键数值与推荐

  • 体外敏感性:4种根管病原菌(Parvimonas micra、Streptococcus intermedius、Prevotella intermedia、Fusobacterium nucleatum)均对AZM、AMP、AMX和CLI敏感。
  • 动物实验:C57BL/6J小鼠已存在的根尖周病变治疗10天后评估骨愈合和炎症细胞浸润。
  • 机制实验:AZM抑制病原菌刺激的NF-κB活化和IL-1α、TNF-α产生。

临床怎么用

  • AZM可能通过免疫调节促进根尖周病变愈合,但尚需临床试验验证其辅助治疗价值。
  • 选择抗生素时应考虑宿主反应,而不仅限于抗菌敏感性。

局限性

  • 结论基于动物实验和体外实验,需设计良好的临床试验进一步验证。
  • AMP对骨的作用不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The purpose of the present study was to compare the immunomodulatory effect of azithromycin (AZM), ampicillin (AMP), amoxicillin (AMX), and clindamycin (CLI) in vitro and AZM on preexisting periapical lesions compared with AMP. METHODS: The susceptibility of 4 common human endodontic pathogens (Parvimonas micra, Streptococcus intermedius, Prevotella intermedia, and Fusobacterium nucleatum) to AZM, AMP, AMX, and CLI was confirmed by agar disk diffusion assay. Preexisting periapical lesions in C57BL/6J mice were treated with AZM, AMP, or phosphate-buffered saline (PBS). Periapical bone healing and the pattern of inflammatory cell infiltration were evaluated after a 10-day treatment by micro-computed tomographic and histology, respectively. Besides, the effect of antibiotics in pathogen-stimulated nuclear factor kappa B activation and the production of interleukin 1 alpha and tumor necrosis factor alpha was assessed in vitro by luciferase assay and enzyme-linked immunosorbent assay. RESULTS: All examined endodontic pathogens were susceptible to AZM, AMP, AMX, and CLI. AZM significantly attenuated periapical bone loss versus PBS. PBS resulted in widely diffused infiltration of mixed inflammatory cells. By contrast, AZM brought about localized infiltration of neutrophils and M2 macrophages and advanced fibrosis. Although the effect of AMP on bone was uncertain, inflammatory cell infiltration was considerably milder than PBS. However, most macrophages observed seemed to be M1 macrophages. AZM suppressed pathogen-stimulated nuclear factor kappa B activation and cytokine production, whereas AMP, AMX, and CLI reduced only cytokine production moderately. CONCLUSIONS: This study showed that AZM led to the resolution of preexisting experimental periapical inflammation. Our data provide a perspective on host response in antibiotic selection for endodontic treatment. However, well-designed clinical trials are necessary to better elucidate the benefits of AZM as an adjunctive therapy for endodontic treatment when antibiotic therapy is recommended. Although both AZM and AMP were effective on preexisting periapical lesions, AZM led to advanced wound healing, probably depending on its immunomodulatory effect.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Andrada AC, Azuma MM, Furusho H, et al. Immunomodulation Mediated by Azithromycin in Experimental Periapical Inflammation. J Endod. 2020. PMID: 32763436. doi:10.1016/j.joen.2020.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。